We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
46 result(s) found, displaying 21 to 30
-
Australian public assessment report (AusPar)New AusPAR for Xospata (gilteritinib as fumarate) for the treatment of relapsed or refractory acute myeloid leukaemia (AML)
-
-
Prescription medicine registrationActive ingredients: gilteritinib fumarate.
-
Prescription medicine registrationActive ingredients: enzalutamide.
-
Designation or determinationPriority review
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADVAGRAF XL tacrolimus 1 mg prolonged-release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADVAGRAF XL tacrolimus 5 mg prolonged-release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADVAGRAF XL tacrolimus 0.5 mg prolonged-release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XTANDI enzalutamide 40 mg soft capsule blister pack.